Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher beats quarterly estimates on strength in diagnostics business
07:04am, Tuesday, 23'rd Apr 2024
Danaher beat quarterly profit and sales expectations on Tuesday, driven by strength in its diagnostics and bioprocessing businesses, sending shares of the life sciences firm up more than 7% before the
Danaher Reports First Quarter 2024 Results
06:00am, Tuesday, 23'rd Apr 2024
WASHINGTON, April 23, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024. All results in this release reflect only cont
Why Danaher (DHR) Might Surprise This Earnings Season
10:56am, Friday, 19'th Apr 2024
Danaher (DHR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Thursday, 18'th Apr 2024
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
12:01pm, Thursday, 18'th Apr 2024
Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
Curious about Danaher (DHR) Q1 Performance? Explore Wall Street Estimates for Key Metrics
10:21am, Thursday, 18'th Apr 2024
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
Suddenly, There's An Alternative - The Important Case For Wide Moat Dividend Stocks
07:00am, Thursday, 18'th Apr 2024
Short-term bonds currently yield more than stocks, indicating a shift in the investment environment. Investors should focus on companies with healthy balance sheets, pricing power, and that are tradin
Reasons Why Danaher (DHR) Should be in Your Portfolio Now
01:31pm, Friday, 12'th Apr 2024
Danaher (DHR) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for April 2024
04:30pm, Thursday, 11'th Apr 2024
Healthcare's impact on the economy cannot be overstated. According to the American Medical Association, the U.S. spends more than $4 trillion a year on healthcare, which works out to nearly $13,000 pe
Here's Why Danaher (DHR) Gained But Lagged the Market Today
07:06pm, Friday, 05'th Apr 2024
In the closing of the recent trading day, Danaher (DHR) stood at $244.28, denoting a +0.98% change from the preceding trading day.
Investors Heavily Search Danaher Corporation (DHR): Here is What You Need to Know
10:05am, Thursday, 04'th Apr 2024
Danaher (DHR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Danaher (DHR) Suffers a Larger Drop Than the General Market: Key Insights
07:21pm, Tuesday, 02'nd Apr 2024
In the closing of the recent trading day, Danaher (DHR) stood at $245.94, denoting a -0.75% change from the preceding trading day.
Danaher (DHR) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:05pm, Wednesday, 27'th Mar 2024
Danaher (DHR) reachead $248.77 at the closing of the latest trading day, reflecting a +0.12% change compared to its last close.
Wall Street Analysts See Danaher (DHR) as a Buy: Should You Invest?
10:31am, Wednesday, 27'th Mar 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Danaher: All In On Life Sciences, And Market Update
12:31am, Wednesday, 27'th Mar 2024
Danaher Corporation is a leading player in the life science industry, with strong financial performance despite many spin-offs. The healthcare industry is facing challenges due to weak funding and hig
